OIM
TTHI

Oracle Investment Management’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Oracle Investment Management’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,817,972
Closed -$5.61M – 19
2016
Q2 		$5.61M Hold
3,817,972
– – 1.31% 15
2016
Q1 		$4.89M Sell
3,817,972
-90,489
-2% -$105K 1.27% 15
2015
Q4 		$7.5M Sell
3,908,461
-57,561
-1% -$109K 1.3% 17
2015
Q3 		$7.1M Sell
3,966,022
-897,892
-18% -$1.91M 1.45% 18
2015
Q2 		$10.2M Buy
4,863,914
+2,593
+0.1% +$18.2K 1.24% 20
2015
Q1 		$33.2M Hold
4,861,321
– – 4.21% 8
2014
Q4 		$33.2M Buy
4,861,321
+10,000
+0.2% +$64.6K 4.36% 9
2014
Q3 		$33.5M Hold
4,851,321
– – 4.63% 8
2014
Q2 		$32.6M Buy
4,851,321
+563,909
+13% +$3.27M 3.96% 9
2014
Q1 		$34.2M Hold
4,287,412
– – 3.9% 10
2013
Q4 		$24.4M Hold
4,287,412
– – 3.36% 11
2013
Q3 		$17.6M Buy
4,287,412
+700,915
+20% +$2.76M 2.51% 14
2013
Q2 		$11.6M Buy
+3,586,497
New +$10.2M 2% 14

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Oracle Investment Management's TTHI Position: Q3 2016 in Review

Oracle Investment Management sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 3,817,972 shares — an estimated $5.61M sold.

Oracle Investment Management first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $34.2M in Q1 2014. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Oracle Investment Management reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Oracle Investment Management sold 3,817,972 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $5.61M.
  • Oracle Investment Management first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • Oracle Investment Management's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $34.2M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Oracle Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.